{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T19:10:03Z","timestamp":1649013003550},"reference-count":18,"publisher":"Japan Society for Clinical Immunology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2177\/jsci.38.473","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T18:05:57Z","timestamp":1461693957000},"page":"473-479","source":"Crossref","is-referenced-by-count":0,"title":["Marked efficacy of adalimumab for secondary gastrointestinal amyloidosis accompanied with ankylosing spondylitis"],"prefix":"10.2177","volume":"38","author":[{"given":"Takeo","family":"ABE","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"AZUMA","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"KONO","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"HAO","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hyogo Collage of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"HIROTA","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hyogo Collage of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"OGITA","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"YOKOYAMA","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"FURUKAWA","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"YOSHIKAWA","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"HINO","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"SAITO","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"NISHIOKA","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"SEKIGUCHI","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayasu","family":"KITANO","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Schinichiro","family":"TSUNODA","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"MATSUI","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"SANO","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Van der Linden, S., et al.: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. <i>Arthritis Rheum<\/i>. <b>27<\/b>: 361-368, 1984."},{"key":"2","unstructured":"2) Domes, S., et al.: Secondary amyloidosis in ankylosing spondylitis. <i>Rheumatol Int<\/i>. <b>33<\/b>: 1725-1729, 2013."},{"key":"3","unstructured":"3) Gratacos, J., et al.: Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration. <i>J Rheumatol<\/i>. <b>24<\/b>: 912-915, 1997."},{"key":"4","unstructured":"4) \u5ca1\u90e8\u5b8f\u660e\uff0c\u307b\u304b\uff1a\u5f37\u76f4\u6027\u810a\u690e\u708e\u306b\u7d9a\u767a\u3057\u305f\u6d88\u5316\u7ba1\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u4e00\u4f8b\uff0e\u65e5\u6d88\u8a8c\uff0e<b>91<\/b>: 1126-1130, 1994."},{"key":"5","unstructured":"5) \u6642\u677e\u4e00\u6210\uff0c\u307b\u304b\uff1a\u80ba\u30a2\u30b9\u30da\u30eb\u30ae\u30eb\u30b9\u75c7\u3068\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u3092\u5408\u4f75\u3057\u305f\u5f37\u76f4\u6027\u810a\u690e\u708e\u306e\u4e00\u4f8b\uff0e\u65e5\u547c\u5438\u4f1a\u8a8c\uff0e<b>39<\/b>: 847-850, 2001."},{"key":"6","unstructured":"6) Shin, J., et al.: Leuconostoc bacteremia in a patient with amyloidosis secondary to rheumatoid arthritis and tuberculosis arthritis. <i>Mod Rheumatol<\/i>. <b>21<\/b>: 691-695, 2011."},{"key":"7","unstructured":"7) Petre, S., et al.: Gastrointestinal amyloidosis-clinical features,diagnosis and therapy. <i>Aliment Pharmacol Ther<\/i>. <b>27<\/b>: 1006-1016, 2008."},{"key":"8","unstructured":"8) Lachmann, H.J., et al.: Natural history and outcome in systemic AA amyloidosis. <i>N Engl J Med<\/i>. <b>356<\/b>: 2361-2371, 2007."},{"key":"9","unstructured":"9) Gillmore, J.D., et al.: Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. <i>Lancet<\/i>. <b>358<\/b>: 24-29, 2001."},{"key":"10","unstructured":"10) Hagihara, K., et al.: IL-6 plays a critical role in the synergistic induction of human serum amyloid A [SAA] gene when stimulated with pro-inflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. <i>Biochem Biophys Res Commun<\/i>. <b>314<\/b>: 363-369, 2004."},{"key":"11","unstructured":"11) Charles, P., et al.: Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-\u03b1 therapy in rheumatoid arthritis. <i>J Immunol<\/i>. <b>163<\/b>: 1521-1528, 1999."},{"key":"12","unstructured":"12) Nishimoto, N., et al.: Toxicity pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I\/II clinical study. <i>J Rheumtol<\/i>. <b>30<\/b>: 1426-1435, 2003."},{"key":"13","unstructured":"13) Okuda, Y., et al.: Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases. <i>Mod Rheumatol<\/i>. <b>24<\/b>: 137-143, 2014."},{"key":"14","unstructured":"14) \u7530\u6751\u88d5\u662d\uff0c\u307b\u304b\uff1aAA\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u5408\u4f75\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u751f\u7269\u5b66\u7684\u88fd\u5264\u306e\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff1aTNF\u03b1\u963b\u5bb3\u7642\u6cd5\u3068\u6297IL-6\u53d7\u5bb9\u4f53\u6297\u4f53\u7642\u6cd5\u306e\u6bd4\u8f03\uff0e\u5317\u6d77\u9053\u52e4\u533b\u8a8c\uff0e<b>34<\/b>: 11-22, 2012."},{"key":"15","unstructured":"15) Hulda, S., et al.: Inflammatory pathway in spondyloarthritis. <i>Mol Immunol<\/i>. <b>57<\/b>: 28-37, 2014."},{"key":"16","unstructured":"16) Kobayashi, S., et al.: A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis. <i>Mod Rheumatol<\/i>. <b>22<\/b>: 589-597, 2012."},{"key":"17","unstructured":"17) Sieper, J., et al.: Assessment of short-time symptomatic efficacy of tocilizumab in ankylosing spondylitis:result of randomized, placebo-controlled trials. <i>Ann Rheum Dis<\/i>. <b>73<\/b>: 95-100, 2014."},{"key":"18","unstructured":"18) Kodak, S., et al.: Ankylosing spondylitis-related secondary amyloidosis responded well to etanercept: a report of three patients. <i>Clin Rheumatol<\/i>. <b>26<\/b>: 2191-2194, 2007."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["\u5f37\u76f4\u6027\u810a\u690e\u708e\u306b\u4f34\u3046\u6d88\u5316\u7ba1\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306b\u30a2\u30c0\u30ea\u30e0\u30de\u30d6\u304c\u594f\u529f\u3057\u305f\u4e00\u4f8b"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/38\/6\/38_473\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T00:53:51Z","timestamp":1461977631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/38\/6\/38_473\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.38.473","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}